Teva discontinued propofol in 2010, but will reenter the market because of the drug shortage.
Maker Fresenius has increased its drug production, and the FDA will continue to import Propoven, a similar drug, from overseas.
ASA is working closely with the FDA to mitigate and prevent further drug shortages.
More Articles on Anesthesia:
ASA Backs Independent Payment Advisory Board Repeal
Anesthesia Business Consultants Tackles Medical Necessity Confusion
Anesthesia Business Consultants Announces Partnership With Survey Vitals
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
